Components of Extraneous Virus Detected in Rotarix Vaccine; No Known Safety Risk

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Components of Extraneous Virus Detected in Rotarix Vaccine; No Known Safety Risk

Components of Extraneous Virus Detected in Rotarix Vaccine; No Known Safety Risk
Mon, 22 Mar 2010 12:56:00 -0500

FDA is recommending that healthcare practitioners temporarily suspend use of the Rotarix vaccine for rotavirus immunization in the United States while the agency learns more about components of an extraneous virus detected in the vaccine. There is no evidence at this time that this finding poses a safety risk.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420